Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...
Opponents argue that the change could cause current smokers to use more cigarettes to compensate for the lower nicotine ...
Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...
The FDA has set maximum levels for lead in baby food. A new California law requires baby food makers selling products in the ...
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
The recalled "Connie's Thin Crust Cheese Pizza" was issued a Class II risk level by the FDA, the second-most severe risk ...
But consumer advocates say the Food and Drug Administration's new guidance on lead limit in baby food doesn't go far enough.